✦ LIBER ✦

1211 Advanced age and serum ribavirin level affect the degree of hemolytic anemia during the combination therapy of IFN-alpha 2B and ribavirin for chronic hepatitis C

✍ Scribed by KARINO, Y; TOYOTA, J; ARAKAWA, T; KUWATA, Y; AKAIKE, J; OHMURA, T; SATO, T; MATSUSHIMA, T

Book ID: 123077199
Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 129 KB
Volume: 38
Category: Article
ISSN: 0270-9139
DOI: 10.1016/S0270-9139(03)81249-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effect of pegylated interferon-alpha

The effect of pegylated interferon-alpha2b and ribavirin combination therapy for chronic hepatitis C infection in elderly patients

✍ Hiroki Nishikawa; Eriko Iguchi; Yorimitsu Koshikawa; Soichiro Ako; Tadashi Inuzu 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 162 KB

Relationship between the hepatitis C vir

Relationship between the hepatitis C viral load and the serum interferon concentration during the first week of peginterferon-alpha-2b-ribavirin combination therapy

✍ Catherine François; Véronique Descamps; Etienne Brochot; Isabelle Bernard; Valér 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB

In chronic hepatitis C virus (HCV) infections, the current standard of care (combination therapy with pegylated alpha interferon (PEG-IFNalpha) and ribavirin) is only effective in around 50% of cases. The aim of the present study was to analyze the relationship between the HCV load and the PEG-IFN c

Pretreatment Laparoscopic Appearance of

Pretreatment Laparoscopic Appearance of the Liver can Predict Response to Combination Therapy with Interferon Alpha 2B and Ribavirin in Chronic Hepatitis C

✍ Jasmohan S. Bajaj; Enrique Molina; Arie Regev; Eugene R. Schiff; Lennox J. Jeffe 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Changes in the Th1/Th2 ratio during a 24

Changes in the Th1/Th2 ratio during a 24-week course of an interferon alpha-2b plus ribavirin combination therapy for patients with chronic hepatitis C

✍ Tomoko Fujimoto; Masahiko Tomimatsu; Daijiro Iga; Hitoshi Endo; Kuniaki Otsuka 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 277 KB

Phase 2 study of the combination of meri

Phase 2 study of the combination of merimepodib with peginterferon-α2b, and ribavirin in nonresponders to previous therapy for chronic hepatitis C

✍ Patrick Marcellin; Yves Horsmans; Frederik Nevens; Jean-Didier Grange; Jean-Pier 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Accordion Index: A new tool for the pred

Accordion Index: A new tool for the prediction of the efficacy of peg-interferon-α-2b and ribavirin combination therapy for chronic hepatitis C

✍ Takeaki Satoh; Akihide Masumoto 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB